Physician profile
Julia Aronovich
NPI 1619053535
$794.99
in general payments reported to CMS, 2019-2025
17 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2022: $118 · 2023: $37.79 · 2024: $292 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $196.17 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $96.15 | 2024-2025 | Veozah |
| Evofem Biosciences, INC. | $79.22 | 2022-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $63.78 | 2024-2025 | Slynd |
| Organon LLC | $47.52 | 2024 | |
| Sumitomo Pharma America, INC. | $47.08 | 2023-2025 | Myfembree |
| Pfizer INC. | $46.27 | 2022 | |
| Therapeuticsmd, INC. | $45.12 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $30.77 | 2019 | |
| Avion Pharmaceuticals | $21.85 | 2019 | |
| Shire North American Group INC | $21.53 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.19 | 2022 | |
| Coopersurgical, INC. | $20.61 | 2024 | Paragard T 380a |
| Lupin INC. | $19.61 | 2019 | |
| Agile Therapeutics, INC. | $19.55 | 2024 | Twirla |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $18.57 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Aronovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.